The Clinical Outcomes Following Transfer of Blastocysts Cultured From Thawed Cleavage Stage Embryos
Evaluating the Clinical Outcomes Following Transfer of Blastocysts Cultured From Thawed Cleavage Stage Embryos at Royan Institute: A Phase 3, Randomized Controlled Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
-
Tehran, Iran, Islamic Republic of
- Royan Institute
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- The patients with first type of infertility
- Age ≤ 37 years
- Long ovulation induction protocol
Exclusion Criteria:
- Any previous surgery on the uterus and ovaries
- Uterine factor infertility
- Sever Male factor infertility (TESE, TESA ،Oligoteratozoospermia)
- Recurrent abortion
- The women with poor ovarian reserve
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Blastocyst transplantation
The infertile women who underwent intra- uterus transferring of blastocyst from thawed cleavage embryo
|
Intra-uterine transferring of blastocyst from thawed cleavage embryo in infertile women.
|
|
Placebo Comparator: Control
The infertile women who underwent intra- uterus transferring of thawed cleavage embryo.
|
Inta-uterine transferring of thawed cleavage embryo transfer in infertile women.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pregnancy Rate
Time Frame: 4weeks
|
Evaluation of pregnancy rate in women 4 weeks after embryos transfer (ET).
|
4weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Miscarriage Rate
Time Frame: 14 days
|
Evaluation the miscarriage rate in women 14 days after embryo transfer (ET) with BHCG titration.
|
14 days
|
|
Implantation Rate
Time Frame: 14 days
|
Evaluation the implantation rate in women 14 days after embryo transfer (ET) with BHCG titration..
|
14 days
|
|
Ongoing pregnancy rate
Time Frame: 14 days
|
Evaluation the ongoing pregnancy rate in women 14 days after embryo transfer (ET) with BHCG titration..
|
14 days
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: Tahereh Madani, MD, Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran
- Principal Investigator: Poopak Eftekhari-Yazdi, PhD, Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran
- Principal Investigator: Nadia Jahangiri, MSc, Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- Royan-Emb-023
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.